Long-term consequences of childhood-onset congenital adrenal hyperplasia

Best Pract Res Clin Endocrinol Metab. 2002 Jun;16(2):273-88. doi: 10.1053/beem.2002.0198.

Abstract

Congenital adrenal hyperplasia (CAH) is a general term applied to several diseases caused by inherited defects of cortisol synthesis. The most common of these is steroid 21-mono-oxygenase (also termed 21-hydroxylase) deficiency (CAH-21OHD), found in approximately 1:10 000-1:15 000 live births. Potentially lethal adrenal insufficiency is characteristic of about two-thirds to three-quarters of patients with the classic salt-wasting form of CAH-21OHD. Non-salt-wasting forms of CAH-21OHD may be diagnosed based in part on genital ambiguity in affected newborn females, and/or by later evidence of androgen excess in members of either sex. Non-classical CAH-21OHD may be detected in up to 1-3% of certain populations, and is often mistaken for idiopathic precocious pubarche in children or polycystic ovary syndrome in young women. This chapter addresses issues relating to long-term consequences in adult life of CAH-21OHD diagnosed in early childhood or adolescence.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adrenal Hyperplasia, Congenital / complications*
  • Adrenal Hyperplasia, Congenital / diagnosis
  • Adrenal Hyperplasia, Congenital / drug therapy
  • Adrenal Hyperplasia, Congenital / genetics
  • Child
  • Female
  • Glucocorticoids / therapeutic use
  • Growth
  • Humans
  • Hydrocortisone / metabolism
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Outcome
  • Reproduction

Substances

  • Glucocorticoids
  • Hydrocortisone